“A new pre-print Israeli study has found that people with natural immunity to COVID-19 could be 13 times less likely to contract the respiratory virus than those who were solely vaccinated against the disease. [See ‘Comparing SARS-CoV-2 natural immunity,’ medrxiv.org.] Conducted by researchers at Maccabi Healthcare and Tel Aviv University, the yet-to-be peer-reviewed study found that when comparing individuals previously infected with the virus and those that received two jabs of the Pfizer-BioNTech shot, those with natural infection saw greater protection against the delta variant and breakthrough infection. The study ultimately concluded that ‘natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity’ and that ‘individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.’”
“Israeli Study,” The Federalist, Aug. 27, 2021